Detalhe da pesquisa
1.
Low Hepatitis B Core-Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels.
Gastroenterology
; 164(4): 669-679.e6, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36642151
2.
Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion.
Clin Gastroenterol Hepatol
; 22(3): 581-590.e6, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871842
3.
Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antivirals.
J Med Virol
; 96(5): e29675, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38746997
4.
Serum RNase L levels in patients with chronic hepatitis B virus infection.
Hepatol Res
; 54(3): 244-251, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37861347
5.
Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy.
J Formos Med Assoc
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423922
6.
Long-term Evolution of Estimated Glomerular Filtration Rate in Patients With Antiviral Treatment for Hepatitis C Virus Infection.
Clin Gastroenterol Hepatol
; 21(2): 424-434.e5, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35131346
7.
Serial increase and high alpha-fetoprotein levels predict the development of hepatocellular carcinoma in 6 months.
Hepatol Res
; 53(10): 1021-1030, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37291079
8.
Atezolizumab-induced encephalitis with subdural hemorrhage and subarachnoid hemorrhage in a patient with hepatocellular carcinoma.
J Formos Med Assoc
; 122(11): 1208-1212, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37567840
9.
Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy.
J Formos Med Assoc
; 122(7): 564-573, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36872131
10.
Long-term durability of sustained virologic response for hepatitis C virus infection in solid organ transplant recipients receiving direct-acting antivirals.
J Formos Med Assoc
; 122(8): 800-804, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36941177
11.
Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resection.
J Formos Med Assoc
; 122(10): 1008-1017, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37147239
12.
Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine.
Clin Gastroenterol Hepatol
; 20(4): 874-885.e4, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34089852
13.
Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phase.
Am J Gastroenterol
; 117(5): 748-757, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35191399
14.
Influence of daptomycin dose and fosfomycin susceptibility on outcome of vancomycin-resistant Enterococcus faecium bloodstream infections treated with daptomycin and fosfomycin combination.
J Antimicrob Chemother
; 77(5): 1436-1443, 2022 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35141753
15.
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.
J Gastroenterol Hepatol
; 37(10): 1901-1910, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35790343
16.
Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents.
J Formos Med Assoc
; 121(5): 920-929, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34538552
17.
Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis.
J Formos Med Assoc
; 121(3): 703-711, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452785
18.
Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinoma.
J Formos Med Assoc
; 121(8): 1579-1587, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078686
19.
New Approaches to Chronic Hepatitis B.
N Engl J Med
; 388(12): 1148, 2023 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36947479
20.
Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy.
J Viral Hepat
; 28(6): 887-896, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33759290